Getinge AB B

Getinge is engaged in three business areas: Medical Systems, Extended Care and Infection Control. Medical System's product range includes surgical tables, surgical lamps, telemedicine, perfusion products, instruments for bypass operations, ventilators, anesthesia systems, synthetic vascular implants and stents. Extended Care's product range includes bathing and shower solutions, lifting equipment and mattresses for the treatment and prevention of pressure ulcers, as well as service and consulting. Infection Control's product range comprises disinfectors, sterilizers, information technology systems and related equipment, as well as service and consulting.
  • TickerGETI B
  • ISINSE0000202624
  • ExchangeNasdaq Nordic Stockholm
  • SectorHealth Care Equipment & Services
  • CountrySweden

Analysts

With a more favourable environment, GETINGE AB improves to Slightly Positive

GETINGE AB (SE), a company active in the Medical Equipment industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date February 5, 2019, the closing price was SEK 102.50 and its potential was estimated at SEK 107.63.

Christer Magnergård ...
  • Jesper Ingildsen
  • Jon Masdal
  • Karl-Johan Bonnevier
  • Martin Hoang Nguyen
  • Martin Huseby Karlsen
  • Mattias Montgomery
  • Niclas Gehin
  • Nicolas McBeath
  • Ole-Andreas Krohn
  • Patrik Ling

Northern Lights

Nurhayati Wan

Getinge

Nurhayati Wan

Getinge

Nurhayati Wan

Getinge

Nurhayati Wan

Getinge

Nurhayati Wan

Getinge

Nurhayati Wan

Getinge

Patrik Ling

Getinge (Buy, TP: SEK115.00) - Healthy earnings beat

Getinge’s EBITA beat our forecast and consensus by c9% in Q4 2018. The beat was driven by better gross margin than expected and growth in operating expenses being kept at bay. We still believe it will take a while before the company is out of the woods completely but at the same time believe the outlook is better than it has been in a long time. We have upgraded the shares to BUY (HOLD); our new target price, at SEK115 (SEK85), has been adjusted to reflect a more optimistic margin forecast.

Jake Strole

Morningstar | Weakening Profitability Trends at Getinge Seem To Be Moderating, but We're Not Yet in the Clear

No-moat Getinge reported results that we think were generally consistent with expectations, characterized by organic revenue growth in line with management's 2%-4% longer-term target and decelerating margin declines. As we roll and update our model, we don't anticipate making many changes to our longer-term projections or SEK 94 per share fair value estimate. Organic sales in the quarter were up 2.4%, growing 4.9% for the full year. Following the impressive year-to-date performance as of the firm's third quarter, it seemed likely the business would surpass the 2%-4% target for the year. Howev...

1 director bought

A director at Getinge Ab bought 26,509 shares at 81.830SEK and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

Christer Magnergård ...
  • Jesper Ingildsen
  • Jon Masdal
  • Karl-Johan Bonnevier
  • Martin Hoang Nguyen
  • Martin Huseby Karlsen
  • Mattias Montgomery
  • Niclas Gehin
  • Nicolas McBeath
  • Ole-Andreas Krohn
  • Patrik Ling

Northern Lights

Frank Maaø ...
  • Karl-Johan Bonnevier
  • Martin Arnell
  • Ole-Andreas Krohn
  • Patrik Ling
  • Rune Majlund Dahl
  • Simen Mortensen
  • Stefan Gauffin

Northern Lights

Marius Knudssøn ...
  • Nicolay Dyvik
  • Ole-Andreas Krohn
  • Patrik Ling

Northern Lights

Antti Kansanen ...
  • Eivind Sars Veddeng
  • Joachim Gunell
  • Jon Masdal
  • Martin Arnell
  • Martin Huseby Karlsen
  • Niclas Gehin
  • Nicolas McBeath
  • Ole-Andreas Krohn
  • Olof Larshammar
  • Patrik Ling
  • Rune Majlund Dahl
  • Simen Mortensen
  • Stefan Gauffin

Northern Lights

Alexander Aukner ...
  • Antti Kansanen
  • Jon Masdal
  • Marius Knudssøn
  • Martin Arnell
  • Martin Huseby Karlsen
  • Ole-Andreas Krohn
  • Patrik Ling
  • Rune Majlund Dahl
  • Simen Mortensen

Northern Lights

With a more favourable environment, GETINGE AB improves to Slightly Positive

GETINGE AB (SE), a company active in the Medical Equipment industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date February 5, 2019, the closing price was SEK 102.50 and its potential was estimated at SEK 107.63.

Nurhayati Wan

Getinge

null

Nurhayati Wan

Getinge

Nurhayati Wan

Getinge

null

Nurhayati Wan

Getinge

MarketLine Department

Hill-Rom Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Hill-Rom Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Hill-Rom Holdings, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive adv...

GlobalData Department

Getinge AB (GETI B) - Medical Equipment - Deals and Alliances Profile

Summary Getinge AB (Getinge) is a medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators and anesthesia equipment, heart-lung machines with accompanying disposables, equipment and instruments for cardiac surgery, vascular surgery; cardiac assist devices; patient lifting devices, hospital beds, stretchers and couches, mattresses for treating and preventing pressure sores, disinfectors, sterilization equipmen...

GlobalData Department

Getinge AB (GETI B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary Getinge AB (Getinge) is a medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators and anesthesia equipment, heart-lung machines with accompanying disposables, equipment and instruments for cardiac surgery, vascular surgery; cardiac assist devices; patient lifting devices, hospital beds, stretchers and couches, mattresses for treating and preventing pressure sores, disinfectors, sterilization equipmen...

Expert Corporate Governance Service (ECGS)

Etude de l'AG du 04/12/2017

In general, Getinge is in compliance with the Swedish regulations relating to the organisation and procedures of an Extraordinary General Meeting.Under ITEM 7, the board of directors seeks approval to distribute all shares in the wholly-owned subsidiary Arjo to the Company's shareholders. ECGS endorses the view of the board of directors that the proposal to split the Company into two separate listed companies (Getinge and Arjo) could enhance the prerequisites to succesfully develop the respective businesses. In addition, ECGS is generally supportive towards corporate spin-offs as they give s...

Expert Corporate Governance Service (ECGS)

Etude l' AG du 15/08/2017

In general, Getinge is in compliance with the Swedish regulations relating to the organisation and procedures of an Extraordinary General Meeting. Under ITEM 7, it is proposed to add a conversion clause, providing the opportunity to convert series A shares into series B shares, to the Company's Articles of Association. As a matter of principle, we welcome the addition of such a conversion clause. The clause is intended to facilitate the spin-off of the Company's Acute Care Therapies business ("Arjo") to its shareholders. Under the Swedish Companies Act conversion is only possible on a 1:1 basi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch